159 related articles for article (PubMed ID: 15744499)
1. The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.
Hameetman L; Kok P; Eilers PH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
Virchows Arch; 2005 Apr; 446(4):430-7. PubMed ID: 15744499
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
[TBL] [Abstract][Full Text] [Related]
3. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
[TBL] [Abstract][Full Text] [Related]
4. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract][Full Text] [Related]
5. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion.
Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
[TBL] [Abstract][Full Text] [Related]
6. Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling.
Hameetman L; Rozeman LB; Lombaerts M; Oosting J; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
J Pathol; 2006 Aug; 209(4):501-11. PubMed ID: 16755518
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
[TBL] [Abstract][Full Text] [Related]
8. EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis.
Bovée JV; Hameetman L; Kroon HM; Aigner T; Hogendoorn PC
J Pathol; 2006 Jul; 209(3):411-9. PubMed ID: 16622899
[TBL] [Abstract][Full Text] [Related]
9. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
10. Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging.
Bernard SA; Murphey MD; Flemming DJ; Kransdorf MJ
Radiology; 2010 Jun; 255(3):857-65. PubMed ID: 20392983
[TBL] [Abstract][Full Text] [Related]
11. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation.
Zuntini M; Pedrini E; Parra A; Sgariglia F; Gentile FV; Pandolfi M; Alberghini M; Sangiorgi L
Oncogene; 2010 Jul; 29(26):3827-34. PubMed ID: 20418910
[TBL] [Abstract][Full Text] [Related]
12. The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas.
He L; Yang Z; Li Z
Pathol Res Pract; 2016 Jul; 212(7):636-42. PubMed ID: 27155928
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in cartilaginous tumours: a marker for malignancy?
Kunisada T; Moseley JM; Slavin JL; Martin TJ; Choong PF
Pathology; 2002 Apr; 34(2):133-7. PubMed ID: 12009094
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
15. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and prognosis of chondrosarcoma of bone.
Rozeman LB; Hogendoorn PC; Bovée JV
Expert Rev Mol Diagn; 2002 Sep; 2(5):461-72. PubMed ID: 12271817
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic features of osteochondroma with malignant transformation].
Zheng L; Zhang HZ; Huang J; Tang J; Liu L; Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):609-13. PubMed ID: 20079189
[TBL] [Abstract][Full Text] [Related]
18. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
19. Soft tissue osteochondroma: case report and immunohistochemistry for parathyroid hormone-related protein.
Ratcliff JR; Naqvi A; de la Roza G; Strauss JA; Damron TA
Ann Diagn Pathol; 2006 Aug; 10(4):222-9. PubMed ID: 16844564
[TBL] [Abstract][Full Text] [Related]
20. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
